Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update showing LY4052031 being studied in advanced or metastatic urothelial cancer and other solid tumors; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Urothelial Cancer

Drugs mentioned

• LY4052031 (LY4052031)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Solid Tumor, Recurrent Solid Tumor | Phase 1 | Status: RECRUITING